Molecular Medicine |
From INSERM U446 (L.L., C.D., A.-M.L.), Laboratoire de Biochimie Appliquée (M.-L.P., D.G., J.-L.P.) and IFR-75: Institut de signalisation et innovation thérapeutique, Faculté de Pharmacie, Châtenay-Malabry, France; and INSERM U442, IFR: Signalisation cellulaire (L.C., T.C.), Faculté des Sciences Bâtiment 443, Orsay, France.
Correspondence to Anne-Marie Lompré, INSERM U446/IFR-75, Institut de signalisation et innovation thérapeutique, Faculté de Pharmacie, Tour D4, 5 rue JB Clément, 92296 Châtenay-Malabry, France. E-mail anne-marie.lompre{at}egm.u-psud.fr
Little is known regarding the molecular mechanisms of atherogenicity of triglyceride-rich lipoproteins such as very low-density lipoproteins (VLDLs). We examined the effect of VLDL on proliferation of rat aortic smooth muscle cells, intracellular Ca2+ handling, and activity of cAMP-responsive element binding protein (CREB) and nuclear factor of activated T cells (NFAT) transcription factors. VLDL, isolated from human serum, dose- and time-dependently promoted proliferation. After 4 hours of exposure to VLDL (0.15 g/L proteins), the caffeine-induced Ca2+ release was inhibited and the IP3-sensitive Ca2+ release induced by ATP (10 µmol/L) was markedly prolonged. In quiescent cells, CREB was phosphorylated (pCREB) and NFAT was present in the cytosol, whereas in cells exposed to VLDL for 4 to 24 hours, pCREB disappeared and NFAT was translocated to the nucleus. VLDL-induced NFAT translocation and proliferation were blocked by cyclosporin A and LY294002 involving calcineurin and phosphatidylinositol 3-kinase (PI3K) pathways. Indeed, VLDLs rapidly phosphorylate protein kinase B and glycogen synthase kinase-3ß in a PI3K-dependent way. These results provide the first evidence that VLDLs induce smooth muscle cell proliferation by activating the PI3K pathway and nuclear NFAT translocation. Blockade of the Ca2+-induced Ca2+ release mechanism and dephosphorylation of pCREB contribute but were not sufficient to induce a proliferating phenotype.
Key Words: vascular disease smooth muscle calcium signaling transcription factors lipoproteins
This article has been cited by other articles:
![]() |
L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster Am. J. Pathol., July 1, 2007; 171(1): 162 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Jabr, A. J. Wilson, M. H. Riddervold, A. H. Jenkins, B. A. Perrino, and L. H. Clapp Nuclear translocation of calcineurin Abeta but not calcineurin A{alpha} by platelet-derived growth factor in rat aortic smooth muscle Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2213 - C2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson, L. M. Nilsson, Y.-W. Chen, J. D. Molkentin, D. Erlinge, and M. F. Gomez High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 794 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Barlow, P. Rose, R. A. Pulver-Kaste, and K. M. Lounsbury Excitation-transcription coupling in smooth muscle J. Physiol., January 1, 2006; 570(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Wilkerson, T. J. Heppner, A. D. Bonev, and M. T. Nelson Inositol trisphosphate receptor calcium release is required for cerebral artery smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H240 - H247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lipskaia, F. del Monte, T. Capiod, S. Yacoubi, L. Hadri, M. Hours, R. J. Hajjar, and A.-M. Lompre Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat Circ. Res., September 2, 2005; 97(5): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Jackson, Z. Mi, and E. K. Jackson Modulation of Cyclic AMP Production by Signal Transduction Pathways in Preglomerular Microvessels and Microvascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 349 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Zaichuk, E. H. Shroff, R. Emmanuel, S. Filleur, T. Nelius, and O. V. Volpert Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition J. Exp. Med., June 7, 2004; 199(11): 1513 - 1522. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |